Skip to main content
Journal ArticleOPEN ACCESS

Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer

Cochrane Database of Systematic Reviews (2016) 2016(3)
DOI: 10.1002/14651858.CD012112
10Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of intravesically administered Bacillus Calmette-Guérin (BCG) plus interferon(IFN)-alpha(α) compared with BCG alone for treating non-muscle-invasive bladder cancer (NMIBC).

Cite

CITATION STYLE

APA

Shepherd, A. R., Shepherd, E., & Brook, N. R. (2016). Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer. Cochrane Database of Systematic Reviews, 2016(3). https://doi.org/10.1002/14651858.CD012112

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free